Akums Drugs and Pharmaceuticals Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Akums Drugs has announced a board meeting where it approved the consolidated financial results for the quarter ended June 30, 2025. Consolidated revenue from operations stood at ₹1,024.03 Cr, with profit reaching ₹64.69 Cr. The board also re-appointed M/s Vibhor Gupta & Associates as Internal Auditor. Key leadership changes include Mr. Rajkumar Bafna (President – Finance) and Mr. Tarun Kapoor (Sr. VP – IT) being designated as Senior Management Personnel. The company also re-constituted board committees, adding independent directors to Audit, Risk Management, and Stakeholders Relationship Committees. Importantly, Akums confirmed full utilization of IPO funds with no deviations.